Overall survival in renal-cell carcinoma with pazopanib versus sunitinib
- PMID: 24785224
- DOI: 10.1056/NEJMc1400731
Overall survival in renal-cell carcinoma with pazopanib versus sunitinib
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical